FeetMe is a certified medical device company developing smart medical wearables to improve mobility based on connected insoles.
FeetMe is developing innovative connected technologies and services to improve patient outcomes in functional care, track disease evolution, and optimize medication utilization.
FeetMe was founded in 2013 by Alexis Mathieu and is based in Paris, France.
FeetMe's innovative technology allows gait and posture analysis in real-time and real-life conditions. The technology combines pressure sensors, motion sensors and learning algorithms to analyse patients’ functional capacity, as well as empower rehabilitation among sufferers of gait disorders.
FeetMe offers solutions to assess, rehabilitate and assist patients suffering from mobility disorders. They are built around smart devices that combine wearable sensors and embedded smart algorithms. FeetMe's solutions include: FeetMe® Evaluation, FeetMe® Rehabilitation, and FeetMe® Stimulate.
FeetMe proposes the world’s first and most advanced technology platform for real-world disease diagnostics, monitoring and rehabilitation based on movement data. It's device, The FeetMe Insole is a solution for ambulatory gait assesment that combines pressure sensors, motion sensors and an embedded calculation power to allow real time gait parameters assesment.
FeetMe is backed by LBO France, Kurma Diagnostics, Paris Saclay seed fund, Idinvest Partners, Seventure and SOSV. The company raised €9.4M in its latest "Series A" financing on Sep 24, 2019. This brings FeetMe's total funding to €11.8M to date.